Life 2000 Ventilation System
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $157,827 | 2,159 | 1,324 |
| 2020 | $623,585 | 616 | 422 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Charitable Contribution | $574,830 | 4 | 73.6% |
| Unspecified | $82,560 | 6 | 10.6% |
| Food and Beverage | $56,772 | 2,726 | 7.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $53,318 | 9 | 6.8% |
| Honoraria | $5,120 | 15 | 0.7% |
| Consulting Fee | $4,100 | 1 | 0.5% |
| Space rental or facility fees (teaching hospital only) | $3,750 | 5 | 0.5% |
| Travel and Lodging | $824.06 | 4 | 0.1% |
| Gift | $138.88 | 5 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| NOVEL PROPORTIONAL OPEN VENTILATION (POV) DEVICE AND ITS EFFICACY IN MANAGING ACUTE RESPIRATORY FAILURE IN COVID-19 PATIENTS | Hill-Rom Company, Inc | $32,900 | 0 |
| A Novel Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients | Hill-Rom Company, Inc | $24,725 | 0 |
| Novel Proportional Open Ventilation(POV) Device and Its Efficacy in Managing Acute Respiratory Failure in Covid-19 Patients | Hill-Rom Company, Inc | $19,145 | 0 |
| Novel Proportional Open Ventilation(POV) Device and Its Efficacy in Managing Acute Respiratory Failure in Covid-19 Patients | Advanced Respiratory, Inc | $5,790 | 0 |
Top Doctors Receiving Payments for Life 2000 Ventilation System
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Chicago, IL | $661,140 | 15 |
| , D.O | Pulmonary Disease | Philadelphia, PA | $48,720 | 41 |
| , M.D | Pulmonary Disease | Potsdam, NY | $5,691 | 8 |
| , M.D | Critical Care Medicine | Durham, NC | $4,924 | 5 |
| , M.D | Pulmonary Disease | Great Neck, NY | $740.00 | 1 |
| , M.D | Pulmonary Disease | Brooklyn, NY | $431.76 | 8 |
| , NP, PMHNP-BC | Adult Health | Darby, PA | $394.15 | 14 |
| , M.D | Critical Care Medicine | Naperville, IL | $360.00 | 1 |
| , M.D | Pulmonary Disease | Evanston, IL | $360.00 | 1 |
| , MD | Critical Care Medicine | Chicago, IL | $360.00 | 1 |
| Dennis Hong | Pulmonary Disease | Chicago, IL | $360.00 | 1 |
| , M.D | Internal Medicine | Chicago, IL | $360.00 | 1 |
| , M.D | Critical Care Medicine | Chicago, IL | $360.00 | 1 |
| Israel Rubinstein | Critical Care Medicine | Chicago, IL | $360.00 | 1 |
| , MD | Internal Medicine | Deerfield, IL | $360.00 | 1 |
| , M.D | Critical Care Medicine | Paradise, CA | $309.32 | 21 |
| , MD INC | Pulmonary Disease | Temecula, CA | $308.11 | 10 |
| , MD | Pulmonary Disease | Los Angeles, CA | $300.00 | 1 |
| , M.D | Pulmonary Disease | Lagrange, GA | $300.00 | 1 |
| , MD | Internal Medicine | Atlanta, GA | $300.00 | 1 |
| , MD | Internal Medicine | Denver, CO | $300.00 | 1 |
| , MD | Internal Medicine | Boston, MA | $273.28 | 3 |
| , M.D | Internal Medicine | Corpus Christi, TX | $264.97 | 9 |
| , MD | Internal Medicine | Moreno Valley, CA | $263.31 | 9 |
| , M.D | Pulmonary Disease | San Diego, CA | $255.34 | 5 |
Manufacturing Companies
- Hill-Rom Holdings, Inc $574,830
- Advanced Respiratory, Inc $129,414
- Hill-Rom Company, Inc $77,168
Product Information
- Type Device
- Total Payments $781,412
- Total Doctors 1,558
- Transactions 2,775
About Life 2000 Ventilation System
Life 2000 Ventilation System is a device associated with $781,412 in payments to 1,558 healthcare providers, recorded across 2,775 transactions in the CMS Open Payments database. The primary manufacturer is Hill-Rom Holdings, Inc.
Payment data is available from 2020 to 2021. In 2021, $157,827 was paid across 2,159 transactions to 1,324 doctors.
The most common payment nature for Life 2000 Ventilation System is "Charitable Contribution" ($574,830, 73.6% of total).
Life 2000 Ventilation System is associated with 4 research studies, including "NOVEL PROPORTIONAL OPEN VENTILATION (POV) DEVICE AND ITS EFFICACY IN MANAGING ACUTE RESPIRATORY FAILURE IN COVID-19 PATIENTS" ($32,900).